Clinical Trial Update: This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 [Phase 1, Phase 2]

View source ↗

Summary

A double-blind, placebo-controlled Phase 1/2 trial evaluated the tolerability, safety, and immunogenicity of CoviVac, an inactivated whole virion concentrated p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• COVIVAC

Snippet

Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | Conditions: Coronavirus Infections, Vaccine | Phase 1, Phase 2 | Status: COMPLETED